HIV-1 integration sites were characterized in activated and resting CD4+ T cells that were sorted from 4 to 6 annually collected PBMC samples starting during primary HIV-1 infection and followed by on and off ART periods in 10 well-characterized HIV-1–infected individuals of the Zurich Primary HIV Infection Study (43). The gene discussed is CD4; the disease is HIV-1 infection.